Fenwal's talented leadership team has extensive experience in health care management. Now, they lead the way in transforming the future of blood technologies by creating an environment where all Fenwal employees work to meet and exceed your expectations.
Labrum brings extensive leadership experience to the principal position at Fenwal. As chairman and CEO at Cardinal Health in their $70 billion Supply Chain Services group, he built a solid foundation of executive administration and management. He has held various top-tier posts with Allegiance Healthcare Corporation, and he began his career with American Hospital Supply Corporation in 1982 (which became part of Baxter Healthcare in 1985). His last post at Baxter was as president of the southwest region.
Johnson has served in a succession of senior leadership roles for a variety of companies, most recently Dade Behring Inc. Over the years, while in the roles of vice president and corporate controller, he gained invaluable experience running global operations and supply chain from the financial management perspective. Johnson is a certified public accountant and is also certified in production and inventory management.
Visick has vast expertise in overseeing the legal affairs of global corporations. He has served as acting general counsel to General Electric Healthcare's Global Diagnostic Imaging business, and he provided general legal support for the company's Services and X-Ray businesses. Previously, Visick held many senior counsel positions with the Georgia-Pacific Corporation.
From his roles as president of Fund 1 LLC and principal of Cerberus/TenX Capital Partners, and in working with General Electric Company, Monaghan brings extensive experience leading business integration, handling the strategy, finance, and day-to-day dealings involved in corporate mergers and acquisitions. He also gained his certification as a Six Sigma Master Black Belt.
Uchida has extensive leadership experience in guiding the marketing and R&D efforts of global organizations. He has held a succession of senior roles at Dade Behring Inc., including president of their Asia Pacific, North America, and Latin America divisions; and, most recently, president of global manufacturing operations and supply chain. Over the years, Uchida has developed next-generation technology, driven growth in emerging markets, and improved quality and efficiency in manufacturing and supply chain.
Fasetti's vast experience leading human resources strategies and initiatives spans over 20 years in the health care sector. She has held a number of top-level positions at Baxter, Allegiance Healthcare, and Cardinal Health. Most recently she led the human resources team for a $7.2 billion company with 8500 employees. In partnering with the executive team, she helped to drive the strategic and operating agendas and achieve significant financial results. As a member of Cardinal Health's supply-chain services executive committee, Fasetti worked on organizational design and change management for the integration of the company's 2 largest segments.
Orsini brings extensive experience in planning, implementing, and controlling global manufacturing and supply-chain operations from his roles at DIAM USA and Hill-Rom. As chief operating officer for DIAM USA and, prior to that, as senior vice president, global operations and engineering, for Hill-Rom, Orsini has a proven track record of improving performance through process re-engineering and large-scale technical evaluation and implementation.
Gregory held the position of vice president of strategy, business development, and ROW marketing for Fenwal's business while supporting Canada, Asia Pacific, and Latin America in the development of their business models. During his nearly 20 years in transfusion medicine with Fenwal, he has led marketing and sales and business strategy and development on a global scale.
Nowland has 27 years of experience in manufacturing, regulatory, clinical affairs, and quality assurance. His experience spans a wide range of medical device companies including American (Heyer-Schulte), Baxter, Haemonetics, CR Bard, Impella CardioSystems USA, Inc., and Z-Tech, Inc. Most recently, he has held executive positions overseeing regulatory, clinical affairs, and quality assurance.
Hugard brings a wealth of experience both as an integral part of sales and marketing and as day-to-day operations manager and leader of strategic planning. In his previous marketing and management roles, Hugard focused on driving the growth of Fenwal's business in Europe by overseeing all activities related to the business within that region.